High Content Screening Market By 2016

High Content Screening: Pharmaceutical and
Healthcare Segment to Remain Dominant Through
2025

P e r s i s t e n c e M a r k e t R e s e a r c h
Report Media Releases
High Content Screening Market to See Steady Growth, Driven
by Rising Application in Toxicity Studies: PMR Reports
By 2016 end, the global high content screening market is likely to register a value of US$
1.24 Bn. In terms of shipment, the consumption of HCS instruments will reach around 555 units
in 2016. While the pharmaceutical and healthcare segment is expected to register the maximum
consumption of HCS technology and instruments, Western Europe will remain the largest market
in terms of high content screening technology adoption and revenue generation.
Consistent demand for high content screening in order to identify human cell-associated small
molecules, micro-molecules, and peptides, will continue to drive the market for high content
screening globally. Surging biological research and drug discovery activities will also be the
important drivers to the market growth. With growing preference to secondary screening for
toxicity studies, the need for enhanced imaging is also rising, which is considered to be a major
factor boosting the market for high content screening. In addition to burgeoning research in the
field of life science, rising support from governments to research activities will escalate the sales
of HCS instruments.
A Sample of this Report is Available Upon Request @
http://www.persistencemarketresearch.com/samples/12931
Increasing number of biotech and pharmaceutical companies specializing in research is likely to
propel the demand for high content screening technology and devices. A major revenue share
will be contributed by consistent sales of mid-end and high-end HCS instruments. Moreover,
research institutions and educational organizations will also register notable consumption.
Promising emergence of automated cell separation technique and scalability analysis is
anticipated to accelerate market growth further by creating lucrative opportunities for
manufacturers and researchers. Growing need for risks assessment in chronic disease cases is
also considered to be a key factor driving the demand for HCS instruments.
By product, the global high content screening market is likely to gain the maximum traction in the
cell imaging and analysis equipment segment. Software segment is expected register a
discernible growth rate.
Based on application, the primary and secondary screening segment will remain dominant with
over 36% market value share, accounting for the revenues of nearly US$ 459.4 Mn in 2016. With
overall steady growth, this segment is projected to witness a consistently growing Y-o-Y growth
rate post-2016. Toxicity studies segment will however exhibit a higher overall growth rate.
Contributing around 17% share to the entire market revenues in 2016, this segment is
anticipated to exceed a value of US$ 219 Mn. Other application segments include target
identification and validation, compound profiling, and others.
On the basis of end-use, pharmaceutical and healthcare segment will continue its dominance
over biotechnology segment.
By regional analysis, Western Europe will remain the largest revenue generator, accounting for
over US$ 424 Mn in terms of revenues. With over 34% market share in 2016, this segment is
High Content Screening Market

P e r s i s t e n c e M a r k e t R e s e a r c h
expected to continue dominance post-2016. North America will be the second largest market
with nearly 32% market share in 2016, followed by Asia Pacific.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/marketresearch/high-content-screening-market/toc
Some of the key market players include Becton, Dickinson and Company (BD), Thermo Fisher
Scientific Inc., GE Healthcare, Olympus Corporation, PerkinElmer Inc., Merck Millipore
Corporation, Danaher Corporation (Molecular Devices), Yokogawa Electric Corporation, Sysmex
Corporation and Thorlabs Inc. Key players are increasingly concentrating on developing new,
innovative products for enhanced cell analysis.
To Buy Full Report for a Single User @
http://www.persistencemarketresearch.com/checkout/12931
About Us:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a
unique collaboration of data analytics and market research methodology to help businesses
achieve optimal performance.
High Content Screening Market

P e r s i s t e n c e M a r k e t R e s e a r c h
To support companies in overcoming complex business challenges, we follow a multi-disciplinary
approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying
real-time data collection, big data, and customer experience analytics, we deliver business
intelligence for organizations of all sizes.
Our offerings include pre-built reports that address every major sale, customized solutions to
cater to client-specific needs, and consulting services to offer more value addition. Our nextgeneration
research approach for exploring emerging technologies has allowed us to solve the
most complex problems of clients. We do not follow a reactive approach, but a pro-active one.
Expert analysts at PMR keep a tab on next-generation technologies in their R&D phase and
provide the latest insights into these technologies when they are being commercialized. Our
ground-breaking approach allows us to deliver market solutions before the technologies reach
the market.
Our client success stories feature a range of clients from Fortune 500 companies to fast-growing
startups. PMR’s collaborative environment is committed to building industry-specific solutions by
transforming data from multiple streams into a strategic asset.
Contact Us:
Persistence Market Research
90 Sate Street, Suite 700 Albany, NY 12207
Tel: +1-518-618-1030
Email: sales@persistencemarketresearch.com
Website: http://www.persistencemarketresearch.com/
media@persistencemarketresearch.com
Stay updated with our official Blog: http://pmrblog.com
High Content Screening Market